However, most of this evidence comes from case reports and small observational cohorts, with a conspicuous lack of large-scale prospective trials
2018, doi:10.1155/2018/1968450 Tabrizi R, Ostadmohammadi V, Lankarani KB, et al
[11] [12] Dementia: A 2003 Cochrane review sought to determine the safety and efficacy of ALCAR in dementia but the reviewers found only clinical trials studies on Alzheimer's disease
doi: 10.3892/or.2012.2099 217 Garcia-MolinaPSola-LeyvaALuque-NavarroPMLasoARios-MarcoPRiosAet al
Effect of arsenic on growth, oxidative stress, and antioxidant system in rice seedlings
For individuals interested in the potential benefits associated with these peptides such as weight loss, improved body composition, or enhanced recovery there are safer, evidence-based alternatives available through NHS and private healthcare pathways